Description
Neurofilament light chain (NfL) is a major component of the axonal cytoskeleton, providing structural stability and influencing conduction velocity. As a reliable indicator of axonal injury, elevated plasma NfL levels are directly associated with cognitive decline and brain atrophy, making it a “universal” biomarker for neurodegenerative disorders.
Key Features:
- Femtogram-Level Sensitivity: Utilizing single-molecule digital detection, the system captures trace proteins at ultra-low concentrations that conventional ELISA cannot reach, enabling the earliest possible detection of neuronal damage.
- Broad Clinical Utility: Plasma NfL levels serve as a powerful tool for differentiating disease stages and monitoring therapeutic efficacy across a spectrum of conditions, including AD, MS, ALS, and traumatic brain injury.
- Non-Invasive Diagnostic Precision: Optimized for human plasma, this kit provides a practical, patient-friendly alternative to invasive CSF collection, allowing for frequent and safe monitoring of disease progression.
- Rapid & Efficient Workflow: Designed for the Inspirer DX Analyzer, it delivers high-accuracy results in just 20-30 minutes with a minimal 25 μL sample volume.
- Advanced AI Integration: Employs a double-antibody sandwich assay combined with AI-based image recognition to ensure absolute quantification of target molecules.
Technical Specifications:
- Packaging: 48 tests/box or 96 tests/box.
- Sample Type: Human Plasma.
- System Compatibility: Fully optimized for the Inspirer DX Analyzer.
